GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Pre-Tax Income

Vectus Biosystems (ASX:VBS) Pre-Tax Income : A$-2.34 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Vectus Biosystems's pretax income for the six months ended in Dec. 2023 was A$-1.18 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.34 Mil. Vectus Biosystems's pretax margin was -117,800.00%.

During the past 9 years, Vectus Biosystems's highest Pretax Margin was -80316.67%. The lowest was -233800.00%. And the median was -80316.67%.


Vectus Biosystems Pre-Tax Income Historical Data

The historical data trend for Vectus Biosystems's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Pre-Tax Income Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only -3.38 -4.80 -3.99 -3.45 -2.13

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.45 -2.14 -1.31 -1.18 -1.16

Competitive Comparison of Vectus Biosystems's Pre-Tax Income

For the Biotechnology subindustry, Vectus Biosystems's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Pre-Tax Income falls into.



Vectus Biosystems Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Vectus Biosystems's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-4.598+1.299+-0.206+0.056+4.4408920985006E-16
=-3.45

Vectus Biosystems's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.822+0.61+-0.003+0.038+-0.0010000000000001
=-1.18

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-2.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectus Biosystems  (ASX:VBS) Pre-Tax Income Explanation

Vectus Biosystems's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-1.178/0.001
=-117,800.00%

During the past 9 years, Vectus Biosystems's highest Pretax Margin was -80316.67%. The lowest was -233800.00%. And the median was -80316.67%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectus Biosystems Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems Business Description

Traded in Other Exchanges
N/A
Address
26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. It operates in one segment, being pharmaceutical research and development.

Vectus Biosystems Headlines

No Headlines